IMMUCELL CORPORATION - COMMON STOCK

NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK

04 июн 2024 08:45:38 Источник NetDania Notify

NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK

31 май 2024 11:04:29 Источник NetDania Notify

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

14 май 2024 15:05:00 Источник Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

08 май 2024 12:00:48 Источник Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

09 апр 2024 15:05:00 Источник Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

27 фев 2024 15:05:00 Источник Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

16 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023

08 янв 2024 15:05:22 Источник Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

13 ноя 2023 15:05:00 Источник Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

07 ноя 2023 11:15:19 Источник Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023

05 окт 2023 15:05:00 Источник Nasdaq GlobeNewswire

ImmuCell Announces Submission of CMC Technical Section to the FDA

29 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023

10 авг 2023 15:05:01 Источник Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023

07 авг 2023 11:00:00 Источник Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023

11 июл 2023 15:05:18 Источник Nasdaq GlobeNewswire

ImmuCell Announces Change in Timing of Anticipated FDA Submission

28 июн 2023 15:05:00 Источник Nasdaq GlobeNewswire

ImmuCell Appoints Bryan K. Gathagan to Board of Directors

21 июн 2023 15:05:22 Источник Nasdaq GlobeNewswire

ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility

15 июн 2023 15:05:02 Источник Nasdaq GlobeNewswire

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

16 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023

11 май 2023 15:05:01 Источник Nasdaq GlobeNewswire